Specialty vaccine company Valneva SE and Pfizer Inc. announced a collaboration to develop VLA15, Valneva’s Lyme disease vaccine candidate, which is currently in Phase 2 clinical studies.
May is Lyme Disease Awareness Month, a time to remind ourselves that Lyme is a disease that has been neglected, minimized, and ridiculed over decades and still continues to be. We all need to redouble our efforts to get an accurate test and to get patients properly treated, and treated with dignity.
May is Lyme Disease Awareness Month, a time to remind ourselves that Lyme is a disease that has been neglected, minimized, and ridiculed over decades and still continues to be. We all need to redouble our efforts to get an accurate test and to get patients properly treated and treated with dignity. The continued arbitrary […]
Lyme Disease Association, Inc., LDA, is proud to celebrate 30 years of advocacy and volunteerism to improve research, education, and patient support surrounding Lyme and tick-borne disease. Early Years By 1990, the total US reported Lyme disease case numbers were 7,943 cases – NJ was second in the nation for the highest number at 1,074 […]
Conference/WG Meeting Clips/Neuropsychiatric Lyme/COVID-19/House Lyme Caucus/Monies for Researchers/WG Meeting Summary/Tickmojis
Important Announcement: The Lyme Disease Association (LDA) and Columbia University have jointly announced our thoughtful but reluctant decision to postpone our annual fall 2020 CME Lyme & Other Tick-Borne Diseases Conference due to the worldwide COVID-19 (SARS-CoV-2) health emergency . The safety and well-being of everyone are our primary concerns, and we hope everyone remains safe.
Elizabeth Maloney, MD, explains current Lyme disease testing issues, including the ELISA and Western Blot, sensitivity and specificity of the testing, and the problems associated with the two-tier testing recommended by the CDC. It begins with the general characteristics of diagnostic testing The Summary states: “Serologic testing for Lyme is inaccurate. While the inadequate sensitivity […]
The following is a list of studies using Hydroxychloroquine for early COVID disease compiled from ClinicalTrials.gov on April 24, 2020. Studies using Hydroxy + Azithromycin: Rutgers, The State University of New Jersey Hydroxy + Zith vs Hydroxy alone vs. no treatment PCR + with T 100.6 or more Inpatient or outpatient Recruiting LCMC Health (New […]
Dr. Richard Horowitz, Dr. Phyllis Freeman, and James Bruzzese have published their case report, “Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases” evaluating two patients with Lyme disease and COVID-19 in Respiratory Medicine Case Reports.
On April 9th, Rep. Chris Smith sent a letter to Health and Human Services (HHS) Secretary Alex Azar and the National Institute for Allergies and Infectious Disease (NIAID) Director, Dr. Anthony Fauci, thanking them for their tireless efforts to address the Coronavirus outbreak as well as expressing his concerns about Lyme disease sufferers and their […]